26 results on '"Youssef Khalil"'
Search Results
2. mRNA therapy restores ureagenesis and corrects glutathione metabolism in argininosuccinic aciduria
- Author
-
Sonam Gurung, Oskar V. Timmermand, Dany Perocheau, Ana Luisa Gil-Martinez, Magdalena Minnion, Loukia Touramanidou, Sherry Fang, Martina Messina, Youssef Khalil, Abigail R. Barber, Richard S. Edwards, Patrick F. Finn, Alex Cavedon, Summar Siddiqui, Lisa Rice, Paolo G.V. Martini, Philippa B. Mills, Simon N. Waddington, Paul Gissen, Simon Eaton, Mina Ryten, Martin Feelisch, Andrea Frassetto, Timothy H. Witney, and Julien Baruteau
- Abstract
Argininosuccinate lyase (ASL) is a key enzyme integral to the hepatic urea cycle which is required for ammonia detoxification, and the citrulline-nitric oxide (NO) cycle for NO production. ASL deficient patients present with argininosuccinic aciduria (ASA), an inherited metabolic disease with hyperammonaemia and a chronic systemic phenotype with neurocognitive impairment and chronic liver disease. ASL deficiency as an inherited model of systemic NO deficiency, shows enhanced nitrosative and oxidative stress. Here, we describe the dysregulation of glutathione biosynthesis and upstream cysteine utilization in ASL-deficient patients and mice using targeted metabolomics andin vivopositron emission tomography (PET) imaging using (S)-4-(3-18F-fluoropropyl)-L-glutamate ([18F]FSPG). Upregulation of cysteine metabolism contrasted with glutathione depletion and down-regulated antioxidant pathways.hASLmRNA encapsulated in lipid nanoparticles corrected and rescued the neonatal and adult Asl-deficient mouse phenotypes, respectively, enhancing ureagenesis and glutathione metabolism and ameliorating chronic liver disease. We further present [18F]FSPG PET as a novel non-invasive diagnostic tool to assess liver disease and therapeutic efficacy in ASA. These findings support clinical translation of mRNA therapy for ASA.
- Published
- 2022
- Full Text
- View/download PDF
3. Human ultrarare genetic disorders of sulfur metabolism demonstrate redundancies in H
- Author
-
Viktor, Kožich, Bernd C, Schwahn, Jitka, Sokolová, Michaela, Křížková, Tamas, Ditroi, Jakub, Krijt, Youssef, Khalil, Tomáš, Křížek, Tereza, Vaculíková-Fantlová, Blanka, Stibůrková, Philippa, Mills, Peter, Clayton, Kristýna, Barvíková, Holger, Blessing, Jolanta, Sykut-Cegielska, Carlo, Dionisi-Vici, Serena, Gasperini, Ángeles, García-Cazorla, Tobias B, Haack, Tomáš, Honzík, Pavel, Ješina, Alice, Kuster, Lucia, Laugwitz, Diego, Martinelli, Francesco, Porta, René, Santer, Guenter, Schwarz, and Peter, Nagy
- Subjects
Humans ,Homeostasis ,Hydrogen Sulfide ,Cysteine ,Sulfides ,Homocysteine ,Sulfur - Abstract
Regulation of H
- Published
- 2022
4. ESDR262 - The Role of Cholesterol in Rare Inflammatory Skin Disease
- Author
-
James McRae, WEi-Li DI, Patricia Barral, Enrica Calvani, Peter Clayton, Philippa Mills, Youssef Khalil, Olumide Ogunbiyi, Nicole Knoepfel, Alicia L. Bruzos, Paulina Stadnik., Connor Hughes, Veronica Kinsler, James ellis, Aimie Sauvadet, Satyamaanasa Polubothu, and Melissa Riachi
- Published
- 2022
- Full Text
- View/download PDF
5. Hereditary polyneuropathy with optic atrophy due to PDXK variant leading to impaired Vitamin B6 metabolism
- Author
-
Natalie Keller, Reza Boostani, Brunhilde Wirth, Ehsan Ghayoor Karimiani, Natalia Mendoza-Ferreira, Henry Houlden, Mert Karakaya, Reza Maroofian, Viorica Chelban, Paria Najarzadeh Torbati, Youssef Khalil, Philippa B. Mills, and Holger Thiele
- Subjects
Male ,0301 basic medicine ,Adolescent ,In silico ,Protein degradation ,Polyneuropathies ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Humans ,Missense mutation ,Pyridoxal phosphate ,Pyridoxal Kinase ,Pyridoxal kinase activity ,Pyridoxal ,Genetics (clinical) ,Exome sequencing ,Molecular biology ,Pyridoxal kinase ,Vitamin B 6 ,Optic Atrophy ,Phosphotransferases (Alcohol Group Acceptor) ,030104 developmental biology ,Neurology ,chemistry ,Pyridoxal Phosphate ,Mutation ,Pediatrics, Perinatology and Child Health ,Female ,Neurology (clinical) ,030217 neurology & neurosurgery - Abstract
PDXK encodes for a pyridoxal kinase, which converts inactive B6 vitamers to the active cofactor pyridoxal 5'-phosphate (PLP). Recently, biallelic pathogenic variants in PDXK were shown to cause axonal Charcot-Marie-Tooth disease with optic atrophy that responds to PLP supplementation. We present two affected siblings carrying a novel biallelic missense PDXK variant with a similar phenotype with earlier onset. After detection of a novel PDXK variant using Whole Exome Sequencing, we confirmed pathogenicity through in silico protein structure analysis, determination of pyridoxal kinase activity using liquid chromatography-tandem mass spectrometry, and measurement of plasma PLP concentrations using high performance liquid chromatography. Our in silico analysis shows a potential effect on PDXK dimer stability, as well as a putative effect on posttranslational ubiquitination that is predicted to lead to increased protein degradation. We demonstrate that the variant leads to almost complete loss of PDXK enzymatic activity and low PLP levels. Our patients' early diagnosis and prompt PLP replacement restored the PLP plasma levels, enabling long-term monitoring of clinical outcomes. We recommend that patients presenting with similar phenotype should be screened for PDXK mutations, as this is a rare opportunity for treatment.
- Published
- 2020
- Full Text
- View/download PDF
6. Organic Solute Transporter Alpha Deficiency: A Disorder With Cholestasis, Liver Fibrosis, and Congenital Diarrhea
- Author
-
Nihan Erden, Carol J. Soroka, James L. Boyer, Youssef Khalil, Iqra Mushtaq, Silvia Vilarinho, Emily Gao, Dhanpat Jain, Pramod K. Mistry, Richard P. Lifton, Huma Arshad Cheema, Peter E. Clayton, Carol Nelson-Williams, and Nadia K. Waheed
- Subjects
Diarrhea ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Liver fibrosis ,Alpha (ethology) ,medicine.disease_cause ,Gastroenterology ,Article ,Receptors, G-Protein-Coupled ,Cholestasis ,Internal medicine ,Humans ,Medicine ,Receptor ,Mutation ,Hepatology ,business.industry ,Transporter ,medicine.disease ,Pedigree ,Liver ,Child, Preschool ,Congenital diarrhea ,business ,Liver pathology - Published
- 2020
- Full Text
- View/download PDF
7. EMT- associated Gene Regulatory Networks in development and disease
- Author
-
Narwade, Nitin, Kass Youssef, Khalil, and Nieto, M. Ángela
- Abstract
Resumen del trabajo presentado al 19th International Congress of Developmental Biology, celebrado en El Algarve (Portugal) del 16 al 20 de octubre de 2022., Epithelial cells lose their apico-basal polarity and cell-cell adhesion properties when undergoing phenotypic changes associated with the Epithelial to Mesenchymal Transition (EMT), which helps them to acquire a migratory behaviour. EMT plays an important role during embryonic development and adult disease progression, including cancer and fibrosis (Nieto, 2016). The Neural Crest (NC) is the best studied model of developmental EMT programmes. NC cells are multipotent embryonic progenitors, which delaminate from the neural tu be during late gastrulation stages of vertebrate embryonic development. By undergoing EMT, NC cells migrate to different parts of embryo where they give rise to different tissues. The EMT develops as a series of molecular events, where the expression of many genes is spatiotemporally regulated by different mechanisms including transcriptional changes, epigenetic regulation and activation of miRNAs, among others. Key players are the so called EMT transcription factors (EMT-TFs), including Snail, Zeb, Twist and Prrx families, which initiate and/or maintain EMT and, when downregulated, can revert the programme. Regulation of target genes by the EMT-TFs leads to the existence of gene regulatory networks (GRNs). We have studied the EMT programme using in-house generated as well as publicly available scRNA-seq data from neural crest and models of cancer and fibrosis. Furthermore, we are building scRNA-Seq based EMT-specific GRNs also inferring both commonalities and specificities in the different contexts to get further insight into this pleiotropic programme that shapes the embryo and favours the progression of devastating diseases.
- Published
- 2022
8. Epithelial to mesenchymal transition trajectories in developmental and disease
- Author
-
Kass Youssef, Khalil, Narwade, Nitin, Arcas, Aída, Marquez-Galera, Angel, Jimenez, Raul, Fazilaty, Hassan, López-Blau, Cristina, Moreno-Bueno, Gema, Cano, Amparo, López-Atalaya, José P., and Nieto, M. Ángela
- Abstract
Resumen del trabajo presentado al 19th International Congress of Developmental Biology, celebrado en El Algarve (Portugal) del 16 al 20 de octubre de 2022., The Epithelial to Mesenchymal transition (EMT) triggers cell plasticity during embryonic development and tissue repair, but it can also promote tumor progression and organ degeneration. The reactivation of EMT in the adult promotes cell dedifferentiation and profound remodeling of the epithelial program, leading to multiple phenotypes, observed in response to injury, during organ fibrosis and cancer cell dissemination. Despite recent advances, identifying universal EMT molecular signatures and understanding how EMT can instructs different outcomes have remained elusive due to the intrinsic complexity and heterogeneity of the process. We have dissected how EMT transcription factors (EMT-TFs) orchestrate TGFBinduced EMT including phenotypic and behavioral states. Further, we have combined lineage tracing and single-cell transcriptomics in three EMT contexts, namely the neural crest, renal fibrosis, and breast cancer to reveal conserved EMT transcription factor codes and signaling pathways that discriminate different EMT states. After inferring cellular trajectories, we have reconstructed the evolution of EMT phenotypic and functional states in all these contexts. Finally, multiplex labeling allowed to spatially allocate distinct EMT programs in mouse and human tumor samples. Altogether, this work unveils distinct EMT trajectories in development and disease, which should also help propase improved therapeutic strategies for organ fibrosis and cancer.
- Published
- 2022
9. Contribution of the epithelial-to-mesenchymal transition transcription factor PRRX1 to melanoma progression and plasticity
- Author
-
Cabello-Torres, Francisco M., Kass Youssef, Khalil, Nieto, M. Ángela, and Sánchez-Laorden, Berta
- Abstract
[Introduction]: Melanoma is a very aggressive skin cancer, known for its high degree of plasticity and heterogeneity that confers high metastatic capabilities and resistance to therapies. Increasing evidences indicate that melanoma progression is not only regulated by mutationdriven mechanisms but also by non-genetic mechanisms that play an important role in melanoma phenotypic plasticity. The reactivation of the expression of neural crest genes in melanoma is associated to progression and resistance to therapies. Among those, epithelialto-mesenchymal transcription factors (EMT-TFs) have been proposed to regulate reversible switches between phenotypic states driving melanoma progression. However the role of Prrx1, an important EMT inducer also expressed during neural crest development, has not been investigated in detail., [Material and Methods]: We have generated a clinically relevant melanoma mouse model that cannot reactivate Prrx1 expression in melanocytes to address the contribution of this EMT-TF to melanoma initiation, progression and responses to therapies., [Results and Discussions]: We have found that Prrx1 is expressed in melanoma and that Prrx1 down-regulation induces cell cycle retention and reduces cell proliferation and cancer stem-like properties in melanoma cells., [Conclusion]: We have detected an effect of Prrx1 on proliferation in melanoma cell lines and their stem cell abilities, but we are still characterizing the effect of this transcription factor in vivo to melanoma initiation, progression and responses to therapies.
- Published
- 2022
10. Real Life Pollution Measurement of Cairo
- Author
-
Youssef Khalil, Mariam Zaky, Mostafa ElHayani, and Hassan Soubra
- Published
- 2022
- Full Text
- View/download PDF
11. Two distinct epithelial to mesenchymal transition programmes. Control invasion and inflammation in segregated tumour cell populations
- Author
-
Kass Youssef, Khalil, Narwade, Nitin, Arcas, Aída, Marquez-Galera, Angel, Jimenez, Raul, López-Blau, Cristina, Fazilaty, Hassan, García-Gutiérrez, David, Cano, Amparo, Galcerán, Joan, Moreno-Bueno, Gema, López-Atalaya, José P., and Nieto, M. Ángela
- Abstract
Resumen del trabajo presentado al 19th Christmas Meeting del Instituto de Neurociencias (CSIC-UMH) celebrado el 21 de diciembre de 2022., Epithelial plasticity is at the core of crucial processes including embryonic cell migration, cancer progression, organ tibrosis and tissue repair. The epithelial to mesenchymal transition (EMT) triggers cell plasticity in all these contexts, highlighting its pleiotropy and intrinsic complcxity. Seminal studies have classified EMT states in cancer celllines and animal modcls. This varicty ofEMT phenotypes necds further investigation, particularly those relevant to the progression ofprevalent and dcvastating diseases such as cancer. Our objcctive is to analyse at single-cell level how different EMT states are established in tumours and if different EMT states pcrform different functions during tumour progression.
- Published
- 2022
12. Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation
- Author
-
Youssef Khalil, Sara Carrino, Fujun Lin, Anna Ferlin, Heena V. Lad, Francesca Mazzacuva, Sara Falcone, Natalie Rivers, Gareth Banks, Danilo Concas, Carlos Aguilar, Andrew R. Haynes, Andy Blease, Thomas Nicol, Raya Al-Shawi, Wendy Heywood, Paul Potter, Kevin Mills, Daniel P. Gale, and Peter T. Clayton
- Subjects
Male ,PPARs ,QH301-705.5 ,Kidney ,liver ,Article ,Catalysis ,Inorganic Chemistry ,Gene Knockout Techniques ,Mice ,proteomics ,Phytol ,Animals ,Cytochrome P450 Family 4 ,Carbon-Carbon Lyases ,Physical and Theoretical Chemistry ,Biology (General) ,Cytochrome P450 Family 2 ,Molecular Biology ,QD1-999 ,Spectroscopy ,peroxisomes ,isoprenoids ,Fatty Acids ,Organic Chemistry ,Brain ,General Medicine ,Computer Science Applications ,Phytanic Acid ,Chemistry ,Lipidomics ,Female ,Oxidation-Reduction - Abstract
Peroxisomal fatty acid α-oxidation is an essential pathway for the degradation of β-carbon methylated fatty acids such as phytanic acid. One enzyme in this pathway is 2-hydroxyacyl CoA lyase (HACL1), which is responsible for the cleavage of 2-hydroxyphytanoyl-CoA into pristanal and formyl-CoA. Hacl1 deficient mice do not present with a severe phenotype, unlike mice deficient in other α-oxidation enzymes such as phytanoyl-CoA hydroxylase deficiency (Refsum disease) in which neuropathy and ataxia are present. Tissues from wild-type and Hacl1−/− mice fed a high phytol diet were obtained for proteomic and lipidomic analysis. There was no phenotype observed in these mice. Liver, brain, and kidney tissues underwent trypsin digestion for untargeted proteomic liquid chromatography-mass spectrometry analysis, while liver tissues also underwent fatty acid hydrolysis, extraction, and derivatisation for fatty acid gas chromatography-mass spectrometry analysis. The liver fatty acid profile demonstrated an accumulation of phytanic and 2-hydroxyphytanic acid in the Hacl1−/− liver and significant decrease in heptadecanoic acid. The liver proteome showed a significant decrease in the abundance of Hacl1 and a significant increase in the abundance of proteins involved in PPAR signalling, peroxisome proliferation, and omega oxidation, particularly Cyp4a10 and Cyp4a14. In addition, the pathway associated with arachidonic acid metabolism was affected; Cyp2c55 was upregulated and Cyp4f14 and Cyp2b9 were downregulated. The kidney proteome revealed fewer significantly upregulated peroxisomal proteins and the brain proteome was not significantly different in Hacl1−/− mice. This study demonstrates the powerful insight brought by proteomic and metabolomic profiling of Hacl1−/− mice in better understanding disease mechanism in fatty acid α-oxidation disorders.
- Published
- 2022
13. Human ultrarare genetic disorders of sulfur metabolism demonstrate redundancies in H2S homeostasis
- Author
-
Viktor Kožich, Bernd C Schwahn, Jitka Sokolová, Michaela Křížková, Tamas Ditroi, Jakub Krijt, Youssef Khalil, Tomáš Křížek, Tereza Vaculíková-Fantlová, Blanka Stibůrková, Philippa Mills, Peter Clayton, Kristýna Barvíková, Holger Blessing, Jolanta Sykut-Cegielska, Carlo Dionisi-Vici, Serena Gasperini, Ángeles García-Cazorla, Tobias B Haack, Tomáš Honzík, Pavel Ješina, Alice Kuster, Lucia Laugwitz, Diego Martinelli, Francesco Porta, René Santer, Guenter Schwarz, and Peter Nagy
- Subjects
Organic Chemistry ,Clinical Biochemistry ,Biochemistry - Published
- 2022
- Full Text
- View/download PDF
14. Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
- Author
-
Peter E. Clayton, Miles Trupp, Anders Öhman, Youssef Khalil, Buket Dalgic, Paul R.S. Baker, William J. Griffiths, Yuqin Wang, Manuela Pacciarini, Silvia Vilarinho, Sinan Sari, Lars Forsgren, Alison Dickson, Eylan Yutuc, Ludger Schöls, Philip Höflinger, Lisa Connell, Lauren Griffiths, and University of St Andrews. School of Medicine
- Subjects
medicine.drug_class ,QH301 Biology ,Hydroxycholesterol ,02 engineering and technology ,Bile acid ,Isotope dilution ,Mass spectrometry ,Tandem mass spectrometry ,01 natural sciences ,Biochemistry ,Mass Spectrometry ,Article ,Analytical Chemistry ,QH301 ,chemistry.chemical_compound ,Liquid chromatography–mass spectrometry ,Cholestenoic acid ,Analytisk kemi ,medicine ,polycyclic compounds ,Environmental Chemistry ,Humans ,QD ,Spectroscopy ,Chromatography ,Cholesterol ,010401 analytical chemistry ,DAS ,Oxysterols ,Isotope-labelled standard ,QD Chemistry ,021001 nanoscience & nanotechnology ,Sterol ,0104 chemical sciences ,LC-MS ,Sterols ,chemistry ,ddc:540 ,lipids (amino acids, peptides, and proteins) ,0210 nano-technology ,Derivatisation ,Saponification ,Chromatography, Liquid - Abstract
Both plasma and cerebrospinal fluid (CSF) are rich in cholesterol and its metabolites. Here we describe in detail a methodology for the identification and quantification of multiple sterols including oxysterols and sterol-acids found in these fluids. The method is translatable to any laboratory with access to liquid chromatography – tandem mass spectrometry. The method exploits isotope-dilution mass spectrometry for absolute quantification of target metabolites. The method is applicable for semi-quantification of other sterols for which isotope labelled surrogates are not available and approximate quantification of partially identified sterols. Values are reported for non-esterified sterols in the absence of saponification and total sterols following saponification. In this way absolute quantification data is reported for 17 sterols in the NIST SRM 1950 plasma along with semi-quantitative data for 8 additional sterols and approximate quantification for one further sterol. In a pooled (CSF) sample used for internal quality control, absolute quantification was performed on 10 sterols, semi-quantification on 9 sterols and approximate quantification on a further three partially identified sterols. The value of the method is illustrated by confirming the sterol phenotype of a patient suffering from ACOX2 deficiency, a rare disorder of bile acid biosynthesis, and in a plasma sample from a patient suffering from cerebrotendinous xanthomatosis, where cholesterol 27-hydroxylase is deficient., Graphical abstract Image 1, Highlights • Absolute quantification of oxysterols and cholestenoic acids. • Methodology applicable to plasma and cerebrospinal fluid. • Data generated for non-esterified and total sterols. • Diastereoisomers at C-24 and C-25 separated and quantified.
- Published
- 2021
- Full Text
- View/download PDF
15. Contribution of the epithelial-to-mesenchymal transition transcription factor PRRX1 to melanoma plasticity and progression
- Author
-
Cabello-Torres, Francisco M., Kass Youssef, Khalil, Nieto, M. Ángela, and López Sánchez-Laorden, Berta
- Abstract
Resumen del póster presentado al 18th International Congress of the Society for Melanoma Research, celebrado online del 28 al 31 de octubre de 2021., Melanoma is a very aggressive skin cancer, known for its high degree of plasticity and heterogeneity that confers high metastatic capabilities and resistance to therapies. Increasing evidences indicate that melanoma progression is not only regulated by mutation-driven mechanisms but also by non-genetic mechanisms that play an important role in melanoma phenotypic plasticity. The reactivation of the expression of neural crest genes in melanoma is associated to progression and resistance to therapies. Among those, epithelial-to-mesenchymal transcription factors (EMT-TFs) have been proposed to regulate reversible switches between phenotypic states driving melanoma progression. However the role of Prrx 1, an important EMT inducer also expressed during neural crest development, has not been investigated in detail. We have found that Prrx1 is expressed in melanoma and that Prrx1 downregulation induces cell cycle retention and reduces cell proliferation and cancer stem-like properties in melanoma cells. We have also generated a clinically relevant melanoma mouse model that cannot reactivate Prrx 1 expression in melanocytes to address the contribution ofthis EMT-TF to melanoma initiation, progression and responses to therapies.
- Published
- 2021
16. Beclin‐1‐mediated activation of autophagy improves proximal and distal urea cycle disorders
- Author
-
Simon N. Waddington, Julien Baruteau, Andrea Motta, Gemma Bruno, Carmine Settembre, Youssef Khalil, Andrés F. Muro, Simon Eaton, Leandro R. Soria, Giulia De Sabbata, Elena Polishchuk, Michael Orford, Nicola Brunetti-Pierri, Debora Paris, Sonam Gurung, Philippa B. Mills, Dany P. Perocheau, Paola Cuomo, Angela De Angelis, Soria, L. R., Gurung, S., De Sabbata, G., Perocheau, D. P., De Angelis, A., Bruno, G., Polishchuk, E., Paris, D., Cuomo, P., Motta, A., Orford, M., Khalil, Y., Eaton, S., Mills, P. B., Waddington, S. N., Settembre, C., Muro, A. F., Baruteau, J., and Brunetti Pierri, N.
- Subjects
0301 basic medicine ,Medicine (General) ,autophagy ,medicine.medical_specialty ,Orotic acid ,Urinary system ,Cell ,Ornithine transcarbamylase ,QH426-470 ,Pharmacology ,Article ,Mice ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,argininosuccinic aciduria ,Internal medicine ,Genetics ,medicine ,Animals ,Urea Cycle Disorders, Inborn ,Tat-Beclin-1 peptide ,business.industry ,Autophagy ,OTC deficiency ,Hyperammonemia ,Articles ,urea cycle disorders ,medicine.disease ,Argininosuccinate lyase ,Ornithine Carbamoyltransferase Deficiency Disease ,Tat‐Beclin‐1 peptide ,medicine.anatomical_structure ,030104 developmental biology ,Endocrinology ,Argininosuccinic aciduria ,Urea cycle ,Molecular Medicine ,Autophagy & Cell Death ,Beclin-1 ,Genetics, Gene Therapy & Genetic Disease ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Urea cycle disorders (UCD) are inherited defects in clearance of waste nitrogen with high morbidity and mortality. Novel and more effective therapies for UCD are needed. Studies in mice with constitutive activation of autophagy unravelled Beclin‐1 as druggable candidate for therapy of hyperammonemia. Next, we investigated efficacy of cell‐penetrating autophagy‐inducing Tat‐Beclin‐1 (TB‐1) peptide for therapy of the two most common UCD, namely ornithine transcarbamylase (OTC) and argininosuccinate lyase (ASL) deficiencies. TB‐1 reduced urinary orotic acid and improved survival under protein‐rich diet in spf‐ash mice, a model of OTC deficiency (proximal UCD). In AslNeo/Neo mice, a model of ASL deficiency (distal UCD), TB‐1 increased ureagenesis, reduced argininosuccinate, and improved survival. Moreover, it alleviated hepatocellular injury and decreased both cytoplasmic and nuclear glycogen accumulation in AslNeo/Neo mice. In conclusion, Beclin‐1‐dependent activation of autophagy improved biochemical and clinical phenotypes of proximal and distal defects of the urea cycle., Using mice with constitutive activation of autophagy and treating mice deficient for ornithine transcarbamylase (OTC) and argininosuccinate lyase (ASL) with the autophagy inducing Tat‐Beclin‐1 (TB‐1), this study shows that Beclin‐1‐dependent activation of autophagy improves the phenotypes of proximal and distal defects of the urea cycle.
- Published
- 2020
- Full Text
- View/download PDF
17. The control of epithelial mesenchymal transitional states
- Author
-
Kass Youssef, Khalil
- Abstract
Trabajo presentado al 17th Meeting of the Spanish Society for Developmental Biology (SEBD), celebrado de forma virtual del 18 al 20 de noviembre de 2020.
- Published
- 2020
18. Prrx1 at the crossroads of epithelial plasticity
- Author
-
Kass Youssef, Khalil
- Abstract
Trabajo presentado al Seminario de Neurobiología del Desarrollo, celebrado online el 12 de mayo de 2020.
- Published
- 2020
19. Comparative proximity biotinylation implicates RAB18 in sterol mobilization and biosynthesis
- Author
-
Robert S. Kiss, Jarred Chicoine, Youssef Khalil, Robert Sladek, He Chen, Alessandro Pisaturo, Cyril Martin, Jessica D. Dale, Tegan A. Brudenell, Archith Kamath, Emanuele Paci, Anja Kerksiek, Dieter Lütjohann, Peter Clayton, Jimi C. Wills, Alex von Kriegsheim, Tommy Nilsson, Eamonn Sheridan, and Mark T. Handley
- Subjects
Nucleotide exchange factor ,chemistry.chemical_compound ,Biosynthesis ,chemistry ,biology ,Microtubule ,Biotinylation ,EMOPAMIL-BINDING PROTEIN ,biology.protein ,Lathosterol ,RAB18 ,Sterol ,Cell biology - Abstract
Loss of functional RAB18 causes the autosomal recessive condition Warburg Micro syndrome. To better understand this disease, we used proximity biotinylation to generate an inventory of potential RAB18 effectors. A restricted set of 28 RAB18-interactions were dependent on the binary RAB3GAP1-RAB3GAP2 RAB18-guanine nucleotide exchange factor (GEF) complex. 12 of these 28 interactions are supported by prior reports and we have directly validated novel interactions with SEC22A, TMCO4 and INPP5B. Consistent with a role for RAB18 in regulating membrane contact sites (MCSs), interactors included groups of microtubule/membrane-remodelling proteins, membrane-tethering and docking proteins, and lipid-modifying/transporting proteins. Two of the putative interactors, EBP and OSBPL2/ORP2, have sterol substrates. EBP (emopamil binding protein) is a Δ8-Δ7 sterol isomerase and OSBPL2/ORP2 is a lipid transport protein. This prompted us to investigate a role for RAB18 in cholesterol biosynthesis. We find that the cholesterol precursor and EBP-product lathosterol accumulates in both RAB18-null HeLa cells and RAB3GAP1-null fibroblasts derived from an affected individual. Further,de novocholesterol biosynthesis is impaired in cells in which RAB18 is absent or dysregulated. Our data demonstrate that GEF-dependent Rab-interactions are highly amenable to interrogation by proximity biotinylation and may suggest that Micro syndrome is a cholesterol biosynthesis disorder.
- Published
- 2019
- Full Text
- View/download PDF
20. Mechanisms underlying melanoma plasticity. Role of EMT-TFS
- Author
-
Cabello-Torres, Francisco M., Kass Youssef, Khalil, Nieto, M. Ángela, and López Sánchez-Laorden, Berta
- Subjects
embryonic structures - Abstract
Resumen del póster presentado al European Developmental Biology Congress (EDBC), celebrado en Alicante del 23 al 26 de octubre de 2019., Melanoma is a very aggressive skin cancer due to its high metastatic abilities. Melanoma arises from melanocytes that derive from highly motile neural crest progenitors that colonize the body during development. The high degree of cell plasticity underlying melanoma metastatic abilities and resistance to therapies is a hallmark of these cells. Although, EMT-TFs (epithelial-to-mesenchymal transition transcription factors) are key regulators of epithelial plasticity in development and in aberrant processes such as fibrosis and cancer, their role in melanoma is far from being understood. E-cadherin loss is a hallmark of EMT, and although melanocytes are not epithelial cells, they express E-cadherin that is lost as melanoma develops, indicating that EMT-TFs may contribute to melanoma initiation. In addition, the reactivation of the expression of neural crest genes in melanoma cells is associated to tumour progression and EMT-TFs reprogramming has been proposed to regulate reversible switches between two phenotypic states (differentiated vs invasive) proposed to control melanoma progression. However, the functional contribution of EMT-TFs, to melanoma initiation and metastasis remains to be elucidated. Our preliminary results indicate that Snail1 and Prrx1, two EMT-TFs expressed in the neural crest among others are expressed in melanomas. We are currently establishing mouse models and functional studies to address their contribution to melanoma biology.
- Published
- 2019
21. The control of epithelial/mesenchymal transitional states
- Author
-
Kass Youssef, Khalil, Fazilaty, Hassan, Arcas, Aída, Abad, Diana, López-Blau, Cristina, Vega, Sonia, and Nieto, M. Ángela
- Subjects
genetic processes ,fungi ,embryonic structures ,natural sciences - Abstract
Resumen del póster presentado al European Developmental Biology Congress (EDBC), celebrado en Alicante del 23 al 26 de octubre de 2019., Transcription factors that trigger Epithelial-to-Mesenchymal Transition (EMT-TFs) are fundamental for the development of multiple tissues and organs. They can be reactivated in pathological conditions resulting in a profound remodeling of epithelial phenotypes, leading to cancer cell dissemination or functional loss in organ fibrosis. Different EMT-TFs can promote distinct EMT programs and, in addition, both embryonic and cancer cells express different combinations of EMT-TFs. Due to this intrinsic complexity, it is unclear how EMT-TFs are coordinated to orchestrate heterogeneous EMT programs, especially the highly plastic and reversible intermediate or partial EMT (pEMT) states. Here, we used in silico, in vitro and in vivo approaches to decipher the relationship between the expression of different EMT-TFs and the resulting phenotypes. (i) Using in silico analysis, we identify a stereotypic EMT-TFs expression-code accompanying the epithelial, hybrid epithelial/mesenchymal (E-M) and mesenchymal (M) phenotypes. (ii) In cultured epithelial kidney cells, TGF-b-induced EMT can associate with partial or full EMT programmes with a stereotypic EMT-TFs expression code. Manipulation of EMT-TFs expression confirms the sequential recruitment of EMT-TFs to fine-tune EMT states. (iii) In renal fibrosis, an in vivo model of pEMT, damaged tubular epithelial cells acquire a stable pEMT phenotype upon the reactivation of specific EMT-TFs, and reminiscent of E-M hybrid phenotype profile identified in our in silico and in vitro analyses. In summary, this work provides evidence for specific combinatorial EMT-TFs codes that regulate the heterogeneity and plasticity of EMT programs leading to different pathological outcomes.
- Published
- 2019
22. Prrx1 isoforms in vascular development
- Author
-
Garcia-Asencio, Francisco, Kass Youssef, Khalil, López-Blau, Cristina, Galcerán, Joan, and Nieto, M. Ángela
- Abstract
Resumen del póster presentado al European Developmental Biology Congress (EDBC), celebrado en Alicante del 23 al 26 de octubre de 2019., También presentado al 16th Christmas Meeting del Instituto de Neurociencias, celebrado en Alicante del 19 al 20 de diciembre de 2019., The epithelial-mesenchymal transition (EMT) endows cells with migratory and invasive properties and it is crucial for the formation of many tissues and organs during embryonic development. This cellular program is triggered after the activation of transcription factors, referred to as EMT-TFs. In the adult, the reactivation of the EMT program contributes to the progression of diseases like fibrosis and cancer (Nieto et al. Cell, 2016). Prrx1, identified as a novel EMT-TF in our lab, produces three different splice isoforms, whose functions remain to be characterized. We have tested the ability of each of these isoforms to induce EMT in vitro, and only the longest isoform (Prrx1L) is able to do so. To test the role of the different isoforms in vivo, we have generated isoform-specific mutant mouse lines that we are characterizing using the phenotype of the Prrx1 null mice in the skeleton and the vasculature (J.F. Martin et al. Genes & Development, 1995, K. Ihida-Stansbury et al. Circulation research, 2004). Using the postnatal retina as a model to study vasculogenesis, we have observed that Prrx1 is specifically expressed in mural cells. Consistent with this expression pattern, we have seen that the Prrx1 isoforms are essential for the integrity of the vasculature in the P6 retina and adult lungs. We are using the in vivo matrigel plug assay to dissect the function of Prrx1 isoforms in mural cells and their interaction with endothelial cells.
- Published
- 2019
23. أثر أحكام الطعن على الحقوق القضائية للمكلفين بضريبة الدخل في فلسطين
- Author
-
وائل يوسف خليل نصار Weal Youssef Khalil Nassar
- Abstract
تتناول هذه الدراسة موضوع حماية المكلفين بضريبة الدخل في فلسطين، سواء في قانون ضريبة الدخل رقم (17) لسنة 2004م الساري فعليا في قطاع غزة أو القرار بقانون رقم(8) لسنة 2011م الساري في الضفة الغربية. وقد اعتمدت الدراسة على المنهج المقارن القائم على التحليل للمواقف التشريعية التي تنظم الحماية القضائية للمكلفين، وتظهر التباين التشريعي في مستوى الحماية التي يوفرها لهم المشرع الفلسطيني وغيره من المشرعين، كما تبين الدراسة مدى تحقق التوازن المطلوب بين طرفي العلاقة الضريبية، سواء أكان التوازن في مرحلة الاعتراض الإداري أم في مرحلة الطعن القضائي، لما لذلك من أثر مباشر في رفع مستوى الامتثال الضريبي، وخفض مستويات التهرب الضريبي. وقد خلصت الدراسة إلى عدد من النتائج، أهمها: أن المشرع الفلسطيني لم يوفر الحماية الكافية للمكلف بالضريبة على الدخل، ولم يحقق التوازن بين طرفي العلاقة الضريبية. كما انتهت إلى عدد من التوصيات، أهمها: ضرورة إجراء التعديل التشريعي اللازم لإعادة بناء منظومة القضاء الضريبي بحيث يتم: تشكيل محكمة بداية ضريبية ذات اختصاص عام، وتشكيل محكمة استئناف ضريبي، وتشكيل نيابة ضريبية، وتأهيل المحاكم والنيابة الضريبية للنظر في الجوانب الضريبية كافة، جزائية كانت أو حقوقية أو إدارية، مع تأهيل الكادر تأهيلا علميا كافيا للاضطلاع بهذا الدور.
- Published
- 2020
- Full Text
- View/download PDF
24. Urea Cycle Related Amino Acids Measured in Dried Bloodspots Enable Long-Term In Vivo Monitoring and Therapeutic Adjustment
- Author
-
Maureen Cleary, Anupam Chakrapani, Simon N. Waddington, Philippa B. Mills, Emma Footitt, Youssef Khalil, James Davison, Paul Gissen, Marta Zancolli, Julien Baruteau, and Stephanie Grunewald
- Subjects
0301 basic medicine ,Endocrinology, Diabetes and Metabolism ,lcsh:QR1-502 ,Tandem mass spectrometry ,Biochemistry ,Article ,lcsh:Microbiology ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,tandem mass spectrometry ,urea cycle ,Deficient mouse ,In patient ,Dried blood ,Molecular Biology ,chemistry.chemical_classification ,amino acids ,Argininosuccinate lyase ,3. Good health ,Amino acid ,argininosuccinate lyase ,030104 developmental biology ,chemistry ,Urea cycle ,dried blood spots ,030217 neurology & neurosurgery - Abstract
Background: Dried bloodspots are easy to collect and to transport to assess various metabolites, such as amino acids. Dried bloodspots are routinely used for diagnosis and monitoring of some inherited metabolic diseases. Methods: Measurement of amino acids from dried blood spots by liquid chromatography-tandem mass spectrometry. Results: We describe a novel rapid method to measure underivatised urea cycle related amino acids. Application of this method enabled accurate monitoring of these amino acids to assess the efficacy of therapies in argininosuccinate lyase deficient mice and monitoring of these metabolites in patients with urea cycle defects. Conclusion: Measuring urea cycle related amino acids in urea cycle defects from dried blood spots is a reliable tool in animal research and will be of benefit in the clinic, facilitating optimisation of protein-restricted diet and preventing amino acid deprivation.
- Published
- 2019
- Full Text
- View/download PDF
25. Defining the clonal dynamics leading to mouse skin tumour initiation
- Author
-
Sánchez-Danés, Adriana, Hannezo, Edouard, Larsimont, Jean-Christophe, Liagre, Mélanie, Youssef, Khalil Kass, Simons, Benjamin D, Blanpain, Cédric, Simons, Benjamin [0000-0002-3875-7071], and Apollo - University of Cambridge Repository
- Subjects
Male ,Tail ,Skin Neoplasms ,Cell Survival ,Apoptosis ,Oncogenes ,Clone Cells ,Mice ,Carcinoma, Basal Cell ,Mutation ,Disease Progression ,Neoplastic Stem Cells ,Animals ,Homeostasis ,Female ,Hedgehog Proteins ,Cell Self Renewal ,Epidermis ,Tumor Suppressor Protein p53 ,Signal Transduction - Abstract
The changes in cell dynamics after oncogenic mutation that lead to the development of tumours are currently unknown. Here, using skin epidermis as a model, we assessed the effect of oncogenic hedgehog signalling in distinct cell populations and their capacity to induce basal cell carcinoma, the most frequent cancer in humans. We found that only stem cells, and not progenitors, initiated tumour formation upon oncogenic hedgehog signalling. This difference was due to the hierarchical organization of tumour growth in oncogene-targeted stem cells, characterized by an increase in symmetric self-renewing divisions and a higher p53-dependent resistance to apoptosis, leading to rapid clonal expansion and progression into invasive tumours. Our work reveals that the capacity of oncogene-targeted cells to induce tumour formation is dependent not only on their long-term survival and expansion, but also on the specific clonal dynamics of the cancer cell of origin.
- Published
- 2016
26. Defining the clonal dynamics leading to mouse skin tumour initiation
- Author
-
Sánchez-Danés, Adriana, Hannezo, Edouard, Larsimont, Jean-Christophe, Liagre, Mélanie, Youssef, Khalil Kass, Simons, Benjamin D, and Blanpain, Cédric
- Subjects
Male ,Tail ,Skin Neoplasms ,Cell Survival ,Apoptosis ,Oncogenes ,3. Good health ,Clone Cells ,Mice ,Carcinoma, Basal Cell ,Mutation ,Disease Progression ,Neoplastic Stem Cells ,Animals ,Homeostasis ,Female ,Hedgehog Proteins ,Cell Self Renewal ,Epidermis ,Tumor Suppressor Protein p53 ,Signal Transduction - Abstract
The changes in cell dynamics after oncogenic mutation that lead to the development of tumours are currently unknown. Here, using skin epidermis as a model, we assessed the effect of oncogenic hedgehog signalling in distinct cell populations and their capacity to induce basal cell carcinoma, the most frequent cancer in humans. We found that only stem cells, and not progenitors, initiated tumour formation upon oncogenic hedgehog signalling. This difference was due to the hierarchical organization of tumour growth in oncogene-targeted stem cells, characterized by an increase in symmetric self-renewing divisions and a higher p53-dependent resistance to apoptosis, leading to rapid clonal expansion and progression into invasive tumours. Our work reveals that the capacity of oncogene-targeted cells to induce tumour formation is dependent not only on their long-term survival and expansion, but also on the specific clonal dynamics of the cancer cell of origin.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.